Back to PRIMECAP MANAGEMENT CO/CA/ PRIMECAP MANAGEMENT CO/CA/

NKTRNKTR
5 quarters

Position history for PRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/'s holdings in NEKTAR THERAPEUTICS

Yes. Primecap holds 272,850 shares of NKTR (Nektar Therapeutics), worth $19M, as of its Q2 2026 13F filing. It reduced the position by 6,300 shares (-2.3%) from Q1 2026. Primecap has held NKTR in every 13F on record since Q2 2025, 5 quarterly filings.

Current Value

$19M

Current Shares

272,850

Total Value Change

+$11.3M

Total Shares Change

-26,868

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
272,850
-2.3%
$19M0.0%$69.81
0
2026-Q1
Decreased
279,150
-0.4%
$20.1M0.0%$71.95
0
2025-Q4
Decreased
280,150
-3.1%
$11.8M0.0%$42.28
0
2025-Q3
Decreased
289,050
-3.6%
$16.4M0.0%$56.90
0
2025-Q2
New
299,718
-
$7.7M0.0%$25.84
38

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used